Aprea Therapeutics | DEFA14A: Others
Aprea Therapeutics | DEF 14A: Definitive information statements
Aprea Therapeutics | 8-K: Current report
Aprea Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Aprea Therapeutics | 8-K: Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
Aprea Therapeutics | 8-K: Current report
Aprea Therapeutics | 8-K: Current report
Aprea Therapeutics | 8-K: Current report
Aprea Therapeutics | 8-K: Current report
Aprea Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Aprea Therapeutics | 8-K: Current report
Aprea Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aprea Therapeutics | 8-K: Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update
Aprea Therapeutics | 8-K: Current report
Aprea Therapeutics | 8-K: Current report
Aprea Therapeutics | 8-K: Current report
Aprea Therapeutics | 8-K: Current report
Aprea Therapeutics | 8-K: Aprea Therapeutics Reports Second Quarter 2023 Financial Results and Provides Update on Business Operations
Aprea Therapeutics | DEF 14A: Definitive information statements
Aprea Therapeutics | 8-K: Current report
No Data